The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(2-methoxyphenyl)piperazin-1-yl)-1-(pyridin-2-yl)-1H-pyrazolo[3,4-d]pyrimidine ID: ALA3780349
PubChem CID: 52149799
Max Phase: Preclinical
Molecular Formula: C21H21N7O
Molecular Weight: 387.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccccc1N1CCN(c2ncnc3c2cnn3-c2ccccn2)CC1
Standard InChI: InChI=1S/C21H21N7O/c1-29-18-7-3-2-6-17(18)26-10-12-27(13-11-26)20-16-14-25-28(21(16)24-15-23-20)19-8-4-5-9-22-19/h2-9,14-15H,10-13H2,1H3
Standard InChI Key: GYBUADPJPWFDQT-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9982 3.0140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2977 3.7689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2918 5.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0102 6.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3063 5.2587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3004 3.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0160 7.5146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2789 8.2718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2706 9.7718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0325 10.5146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3274 9.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3192 8.2575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5843 7.5313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6193 8.1385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2781 -3.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8565 -5.2005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3443 -5.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2537 -4.1987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6753 -2.8147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
2 11 1 0
14 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
23 24 1 0
10 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.45Molecular Weight (Monoisotopic): 387.1808AlogP: 2.55#Rotatable Bonds: 4Polar Surface Area: 72.20Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.83CX LogP: 3.18CX LogD: 3.18Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -1.97
References 1. Siebeneicher H, Bauser M, Buchmann B, Heisler I, Müller T, Neuhaus R, Rehwinkel H, Telser J, Zorn L.. (2016) Identification of novel GLUT inhibitors., 26 (7): [PMID:26949183 ] [10.1016/j.bmcl.2016.02.050 ] 2. Wang, Dasheng and 6 more authors. 2012-04-26 Development of a novel class of glucose transporter inhibitors. [PMID:22468970 ] 3. Siebeneicher, Holger H and 8 more authors. 2016-04-01 Identification of novel GLUT inhibitors. [PMID:26949183 ] 4. Granchi, C; Fortunato, S and Minutolo, F. 2016-09-01 Anticancer agents interacting with membrane glucose transporters. [PMID:28042452 ] 5. Liu, Kevin G and 10 more authors. 2020-05-28 Discovery and Optimization of Glucose Uptake Inhibitors. [PMID:32282207 ]